New Two-in-One diabetes drug tested for better blood sugar control
NCT ID NCT06403761
Summary
This study tested a new investigational medicine called CagriSema, which combines two drugs, to see how it affects the body's insulin sensitivity in people with type 2 diabetes. 158 adults with type 2 diabetes who were already taking metformin received either CagriSema, one of its components, or a placebo for about 42 weeks. The main goal was to measure how well the body uses insulin to control blood sugar.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.